Report Detail

Pharma & Healthcare Global Pain Management Drugs Market Research Report 2018

  • RnM1772768
  • |
  • 21 March, 2018
  • |
  • Global
  • |
  • 116 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

In this report, the global Pain Management Drugs market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Pain Management Drugs in these regions, from 2013 to 2025 (forecast), covering
North America
Europe
China
Japan
Southeast Asia
India
Global Pain Management Drugs market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Merck
Endo International
AstraZeneca
Johnson & Johnson
Pfizer
Purdue Pharma
Hospira
Allergan
El Lilly
Daiichi Sankyo
NeurAxon
Tonix
Immune Pharmaceuticals
Innovative Med Concepts
Zynerba Pharmaceuticals
Sorrento Therapeutics
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Opioids
NSAIDs
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
Musculoskeletal
Surgical and Trauma
Cancer
Obstetrical
Burn
Pediatric Pain
Other

If you have any special requirements, please let us know and we will offer you the report as you want.


Table of Contents

    Global Pain Management Drugs Market Research Report 2018

      1 Pain Management Drugs Market Overview

      • 1.1 Product Overview and Scope of Pain Management Drugs
      • 1.2 Pain Management Drugs Segment by Type (Product Category)
        • 1.2.1 Global Pain Management Drugs Production and CAGR (%) Comparison by Type (Product Category)(2013-2025)
        • 1.2.2 Global Pain Management Drugs Production Market Share by Type (Product Category) in 2017
        • 1.2.3 Opioids
        • 1.2.4 NSAIDs
      • 1.3 Global Pain Management Drugs Segment by Application
        • 1.3.1 Pain Management Drugs Consumption (Sales) Comparison by Application (2013-2025)
        • 1.3.2 Musculoskeletal
        • 1.3.3 Surgical and Trauma
        • 1.3.4 Cancer
        • 1.3.5 Obstetrical
        • 1.3.6 Burn
        • 1.3.7 Pediatric Pain
        • 1.3.8 Other
      • 1.4 Global Pain Management Drugs Market by Region (2013-2025)
        • 1.4.1 Global Pain Management Drugs Market Size (Value) and CAGR (%) Comparison by Region (2013-2025)
        • 1.4.2 North America Status and Prospect (2013-2025)
        • 1.4.3 Europe Status and Prospect (2013-2025)
        • 1.4.4 China Status and Prospect (2013-2025)
        • 1.4.5 Japan Status and Prospect (2013-2025)
        • 1.4.6 Southeast Asia Status and Prospect (2013-2025)
        • 1.4.7 India Status and Prospect (2013-2025)
      • 1.5 Global Market Size (Value) of Pain Management Drugs (2013-2025)
        • 1.5.1 Global Pain Management Drugs Revenue Status and Outlook (2013-2025)
        • 1.5.2 Global Pain Management Drugs Capacity, Production Status and Outlook (2013-2025)

      2 Global Pain Management Drugs Market Competition by Manufacturers

      • 2.1 Global Pain Management Drugs Capacity, Production and Share by Manufacturers (2013-2018)
        • 2.1.1 Global Pain Management Drugs Capacity and Share by Manufacturers (2013-2018)
        • 2.1.2 Global Pain Management Drugs Production and Share by Manufacturers (2013-2018)
      • 2.2 Global Pain Management Drugs Revenue and Share by Manufacturers (2013-2018)
      • 2.3 Global Pain Management Drugs Average Price by Manufacturers (2013-2018)
      • 2.4 Manufacturers Pain Management Drugs Manufacturing Base Distribution, Sales Area and Product Type
      • 2.5 Pain Management Drugs Market Competitive Situation and Trends
        • 2.5.1 Pain Management Drugs Market Concentration Rate
        • 2.5.2 Pain Management Drugs Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Pain Management Drugs Capacity, Production, Revenue (Value) by Region (2013-2018)

      • 3.1 Global Pain Management Drugs Capacity and Market Share by Region (2013-2018)
      • 3.2 Global Pain Management Drugs Production and Market Share by Region (2013-2018)
      • 3.3 Global Pain Management Drugs Revenue (Value) and Market Share by Region (2013-2018)
      • 3.4 Global Pain Management Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
      • 3.5 North America Pain Management Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
      • 3.6 Europe Pain Management Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
      • 3.7 China Pain Management Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
      • 3.8 Japan Pain Management Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
      • 3.9 Southeast Asia Pain Management Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
      • 3.10 India Pain Management Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

      4 Global Pain Management Drugs Supply (Production), Consumption, Export, Import by Region (2013-2018)

      • 4.1 Global Pain Management Drugs Consumption by Region (2013-2018)
      • 4.2 North America Pain Management Drugs Production, Consumption, Export, Import (2013-2018)
      • 4.3 Europe Pain Management Drugs Production, Consumption, Export, Import (2013-2018)
      • 4.4 China Pain Management Drugs Production, Consumption, Export, Import (2013-2018)
      • 4.5 Japan Pain Management Drugs Production, Consumption, Export, Import (2013-2018)
      • 4.6 Southeast Asia Pain Management Drugs Production, Consumption, Export, Import (2013-2018)
      • 4.7 India Pain Management Drugs Production, Consumption, Export, Import (2013-2018)

      5 Global Pain Management Drugs Production, Revenue (Value), Price Trend by Type

      • 5.1 Global Pain Management Drugs Production and Market Share by Type (2013-2018)
      • 5.2 Global Pain Management Drugs Revenue and Market Share by Type (2013-2018)
      • 5.3 Global Pain Management Drugs Price by Type (2013-2018)
      • 5.4 Global Pain Management Drugs Production Growth by Type (2013-2018)

      6 Global Pain Management Drugs Market Analysis by Application

      • 6.1 Global Pain Management Drugs Consumption and Market Share by Application (2013-2018)
      • 6.2 Global Pain Management Drugs Consumption Growth Rate by Application (2013-2018)
      • 6.3 Market Drivers and Opportunities
        • 6.3.1 Potential Applications
        • 6.3.2 Emerging Markets/Countries

      7 Global Pain Management Drugs Manufacturers Profiles/Analysis

      • 7.1 Merck
        • 7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        • 7.1.2 Pain Management Drugs Product Category, Application and Specification
          • 7.1.2.1 Product A
          • 7.1.2.2 Product B
        • 7.1.3 Merck Pain Management Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        • 7.1.4 Main Business/Business Overview
      • 7.2 Endo International
        • 7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        • 7.2.2 Pain Management Drugs Product Category, Application and Specification
          • 7.2.2.1 Product A
          • 7.2.2.2 Product B
        • 7.2.3 Endo International Pain Management Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        • 7.2.4 Main Business/Business Overview
      • 7.3 AstraZeneca
        • 7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        • 7.3.2 Pain Management Drugs Product Category, Application and Specification
          • 7.3.2.1 Product A
          • 7.3.2.2 Product B
        • 7.3.3 AstraZeneca Pain Management Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        • 7.3.4 Main Business/Business Overview
      • 7.4 Johnson & Johnson
        • 7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        • 7.4.2 Pain Management Drugs Product Category, Application and Specification
          • 7.4.2.1 Product A
          • 7.4.2.2 Product B
        • 7.4.3 Johnson & Johnson Pain Management Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        • 7.4.4 Main Business/Business Overview
      • 7.5 Pfizer
        • 7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        • 7.5.2 Pain Management Drugs Product Category, Application and Specification
          • 7.5.2.1 Product A
          • 7.5.2.2 Product B
        • 7.5.3 Pfizer Pain Management Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        • 7.5.4 Main Business/Business Overview
      • 7.6 Purdue Pharma
        • 7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        • 7.6.2 Pain Management Drugs Product Category, Application and Specification
          • 7.6.2.1 Product A
          • 7.6.2.2 Product B
        • 7.6.3 Purdue Pharma Pain Management Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        • 7.6.4 Main Business/Business Overview
      • 7.7 Hospira
        • 7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        • 7.7.2 Pain Management Drugs Product Category, Application and Specification
          • 7.7.2.1 Product A
          • 7.7.2.2 Product B
        • 7.7.3 Hospira Pain Management Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        • 7.7.4 Main Business/Business Overview
      • 7.8 Allergan
        • 7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        • 7.8.2 Pain Management Drugs Product Category, Application and Specification
          • 7.8.2.1 Product A
          • 7.8.2.2 Product B
        • 7.8.3 Allergan Pain Management Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        • 7.8.4 Main Business/Business Overview
      • 7.9 El Lilly
        • 7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        • 7.9.2 Pain Management Drugs Product Category, Application and Specification
          • 7.9.2.1 Product A
          • 7.9.2.2 Product B
        • 7.9.3 El Lilly Pain Management Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        • 7.9.4 Main Business/Business Overview
      • 7.10 Daiichi Sankyo
        • 7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        • 7.10.2 Pain Management Drugs Product Category, Application and Specification
          • 7.10.2.1 Product A
          • 7.10.2.2 Product B
        • 7.10.3 Daiichi Sankyo Pain Management Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        • 7.10.4 Main Business/Business Overview
      • 7.11 NeurAxon
      • 7.12 Tonix
      • 7.13 Immune Pharmaceuticals
      • 7.14 Innovative Med Concepts
      • 7.15 Zynerba Pharmaceuticals
      • 7.16 Sorrento Therapeutics

      8 Pain Management Drugs Manufacturing Cost Analysis

      • 8.1 Pain Management Drugs Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
        • 8.1.4 Market Concentration Rate of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
        • 8.2.1 Raw Materials
        • 8.2.2 Labor Cost
        • 8.2.3 Manufacturing Expenses
      • 8.3 Manufacturing Process Analysis of Pain Management Drugs

      9 Industrial Chain, Sourcing Strategy and Downstream Buyers

      • 9.1 Pain Management Drugs Industrial Chain Analysis
      • 9.2 Upstream Raw Materials Sourcing
      • 9.3 Raw Materials Sources of Pain Management Drugs Major Manufacturers in 2017
      • 9.4 Downstream Buyers

      10 Marketing Strategy Analysis, Distributors/Traders

      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
        • 10.1.3 Marketing Channel Development Trend
      • 10.2 Market Positioning
        • 10.2.1 Pricing Strategy
        • 10.2.2 Brand Strategy
        • 10.2.3 Target Client
      • 10.3 Distributors/Traders List

      11 Market Effect Factors Analysis

      • 11.1 Technology Progress/Risk
        • 11.1.1 Substitutes Threat
        • 11.1.2 Technology Progress in Related Industry
      • 11.2 Consumer Needs/Customer Preference Change
      • 11.3 Economic/Political Environmental Change

      12 Global Pain Management Drugs Market Forecast (2018-2025)

      • 12.1 Global Pain Management Drugs Capacity, Production, Revenue Forecast (2018-2025)
        • 12.1.1 Global Pain Management Drugs Capacity, Production and Growth Rate Forecast (2018-2025)
        • 12.1.2 Global Pain Management Drugs Revenue and Growth Rate Forecast (2018-2025)
        • 12.1.3 Global Pain Management Drugs Price and Trend Forecast (2018-2025)
      • 12.2 Global Pain Management Drugs Production, Consumption , Import and Export Forecast by Region (2018-2025)
        • 12.2.1 North America Pain Management Drugs Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
        • 12.2.2 Europe Pain Management Drugs Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
        • 12.2.3 China Pain Management Drugs Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
        • 12.2.4 Japan Pain Management Drugs Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
        • 12.2.5 Southeast Asia Pain Management Drugs Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
        • 12.2.6 India Pain Management Drugs Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
      • 12.3 Global Pain Management Drugs Production, Revenue and Price Forecast by Type (2018-2025)
      • 12.4 Global Pain Management Drugs Consumption Forecast by Application (2018-2025)

      13 Research Findings and Conclusion

        14 Appendix

        • 14.1 Methodology/Research Approach
          • 14.1.1 Research Programs/Design
          • 14.1.2 Market Size Estimation
          • 14.1.3 Market Breakdown and Data Triangulation
        • 14.2 Data Source
          • 14.2.1 Secondary Sources
          • 14.2.2 Primary Sources

        REPORT YOU MIGHT BE INTERESTED

        Purchase this Report

        $2,900.00
        $5,800.00
        2,296.80
        4,593.60
        2,685.40
        5,370.80
        438,915.00
        877,830.00
        241,860.00
        483,720.00
        Credit card Logo

        Related Reports


        Reason to Buy

        Request for Sample of this report